Publication | Open Access
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study
89
Citations
35
References
2021
Year
<sup>177</sup>Lu-PSMA appeared to be a feasible and safe treatment modality in patients with low-volume mHSPC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1